Shareholder alert: kaskela law llc announces shareholder lawsuit against acadia pharmaceuticals, inc. (nasdaq: acad) and encourages long-term acad investors to contact the firm

Philadelphia , aug. 16, 2023 /prnewswire/ -- kaskela law llc announces that a shareholder class action lawsuit has been filed against acadia pharmaceuticals inc. ("acadia") (nasdaq: acad) on behalf of certain investors who purchased shares of the company's stock between september 9, 2019 and april 4, 2021. as detailed in the complaint, acadia is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that seek to address unmet medical needs in central nervous system disorders.
ACAD Ratings Summary
ACAD Quant Ranking